The DNA microarray market is expanding due to its role in cancer diagnostics and genomic R&D, with significant growth in Asia Pacific.
Increasing application base of microarrays in molecular biology, pharmaceutical target screening, toxicological response profiling, and biomarker identification is driving the global DNA microarray market. With abilities to facilitate the simultaneous comprehensive analysis of numerous genes, DNA microarrays continue to see robust uptake across the clinical laboratories. Alarming rise in the prevalence of cancers across the globe is another strong factor pushing the need for deeper comprehensive R&D, thereby propelling the growth of DNA microarray market. The evolving area of cancer diagnostics is heavily contributing towards the market growth in addition to the growing interest around personalised medicine.
For more insights into the Market, Get a Sample Copy of this Report: https://www.fairfieldmarketresearch.com/report/dna-microarray-market/request-sample
Although next-generation sequencing is emerging highly popular in cytogenetics and diagnostics, DNA microarrays still sustain the demand on account of their price point and a desirable rate of clinical implementation. Rocketing investments in medical and healthcare R&D are also providing the market with a strong impetus to thrive. Adoption is more prominent among public institutes, including academic centres, government laboratories, and clinical research organisations (CROs).
DNA Microarray Witnessing Significant Demand for Early Cancer Diagnosis
With consumables having registered the lion’s share in 2019 global market value, it is expected that the dominance of consumables in terms of demand will be a continued trend in the DNA microarray market throughout the forecast period. This has attributed to growing availability of reagents and auxiliary components that are needed during microarray procedures. The advent of technology in gene expression analysis algorithms is also complementing the market growth. Among end users, research institutes – both government and academic, contributed significantly to the total demand for DNA microarray. With heavy spending of governments on biotechnological R&D, the same trend will mostly continue by 2025.
On the other hand, cancer diagnosis remained the key application area in 2019 as targeted cancer therapies continued to witness mounting demand. Genomic chip arrays are experiencing solid demand growth as they play a crucial role in the optimisation of the various drug discovery processes, including disease pathway identification and validation, and compound screening. In line with this, application of DNA microarray in drug discovery has been growing at an exponential pace. Drug discovery will thus highly likely emerge as the most lucrative application area in the DNA microarray market.
Do You Have Any Query Or Specific Requirement? Request for Custom Research:
https://www.fairfieldmarketresearch.com/report/dna-microarray-market/request-customization
Asia Pacific Provides a Hotspot for Expansion of Companies
North America houses a majority of the established players and is a hub for large-scale projects around genomic R&D. The innovative informatics hub also makes the North American region an attractive market for participants in the DNA microarray market. However, Asia Pacific has been recently emerging lucrative as the awareness about disease risk assessment and disease prevention is picking up in the region, thereby pushing the demand for genetic tests. Asia Pacific is expected to present high-potential growth opportunities to the DNA microarray market on the back of increasing budget allocations of governments towards biotechnology and allied areas. Given the scenario, global (US-based) leaders such as Illumina, Inc. and Affymetrix, Inc. have expanded by setting up their manufacturing facilities in the attractive Asian sub-continent.
Some of the key companies in the DNA microarray space are entering strategic partnerships for better market positioning. Recently, Arizona-based PathogenDx, Inc. joined forces with Prevenio over the development of the industry’s first-ever closed-loop system that would address foodborne pathogens. While the former has developed a multiplexed DNA microarray-based pathogen testing platform, the latter is an innovation leader in automated food processing and pathogen protection systems. Several vendors in the microarrays space are striving to develop innovative storage and analysis solutions for the data generated by microarrays. This would ultimately aid in the applications of microarrays in biomedicine.
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
Follow Us: LinkedIn
The article discusses the growth of the DNA microarray market, especially in cancer diagnostics and genomic R&D.
Asia Pacific is emerging as a key market due to increased government investments in biotechnology.
They are used for gene analysis, cancer diagnostics, drug discovery, and more.
Explore more articles in the Research Reports category
